HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yoshino, S. Search for Related Content PubMed PubMed Citation Articles by Yoshino, S. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Arthritis Joint Disorders

Treatment with an Anti-IL-4 Monoclonal Antibody Blocks Suppression of Collagen-Induced Arthritis in Mice by Oral Administration of Type II Collagen¹

Department of Microbiology, Saga Medical School, Saga, Japan

Oral administration of type II collagen (CII) has been shown to suppress collagen-induced arthritis (CIA) in experimental animals. However, the exact mechanism by which CIA is suppressed following administration of CII remains to be investigated, although it was demonstrated that active suppression by regulatory T cells might be involved in the suppression. Therefore, we have examined whether the inhibitory cytokine IL-4 plays a role in the suppression of CIA, by using an anti-IL-4 mAb (11B11 mAb). Mice were fed daily with CII over a period of 10 days before immunization with CII. 11B11 mAb was i.p. injected 30 min before each oral administration of CII. The results showed that treatment with 11B11 mAb markedly blocked suppression of CIA by the oral Ag. The blockade of suppression of CIA by the anti-IL-4 mAb was associated with the blockade of augmentation of IL-4 secretion in CII-fed mice. The treatment with 11B11 mAb also resulted in the prevention of decreases in anti-CII IgG2a Ab production, DTH responses to CII, proliferation of lymphoid cells to CII, and IFN- secretion in mice given CII orally. Thus, the neutralization of IL-4 by an anti-IL-4 Ab appears to be effective in blocking suppression of CIA by oral administration of CII, suggesting that IL-4 may be critically involved in its suppression.

This article has been cited by other articles:

				S. Yoshino, H. Hayashi, S. Taneda, H. Takano, M. Sagai, and Y. Mori Effect of Diesel Exhaust Particle Extracts on Induction of Oral Tolerance in Mice Toxicol. Sci., April 1, 2002; 66(2): 293 - 297. [Abstract] [Full Text] [PDF]

				S. Yoshino, E. Sasatomi, Y. Mori, and M. Sagai Oral Administration of Lipopolysaccharide Exacerbates Collagen-Induced Arthritis in Mice J. Immunol., September 15, 1999; 163(6): 3417 - 3422. [Abstract] [Full Text] [PDF]

				S. Yoshino and M. Sagai Enhancement of Collagen-Induced Arthritis in Mice by Diesel Exhaust Particles J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 524 - 529. [Abstract] [Full Text]